Inventor · disambiguated record
Allan W. Rey
Also filed as: REY ALLAN · REY ALLAN W
30 granted patents·14 pending applications·169 citations·filing 1993–2024
95Inventor score
Files withAPOTEX INC24APOTEX PHARMACHEM INC10BRANTFORD CHEM INC3BRISTOL MYERS SQUIBB CO2APOTEX PHARMA CHEM INC1
Top patents by PatentIndex Score
44 records- 0195US11377456B2Crystalline form of RemdesivirAPOTEX INC·Filed 2021·Granted Jul 5, 2022·16 cites·21 claims
- 0294US7935817B2Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereofAPOTEX PHARMACHEM INC·Filed 2008·Granted May 3, 2011·24 cites·22 claims
- 0393US5412092AN-substituted 2-azetidinonesBRISTOL MYERS SQUIBB CO·Filed 1993·Granted May 2, 1995·82 cites·8 claims
- 0487US8883795B2Polymorphic forms of RifaximinKOTHAKONDA KIRAN KUMAR·Filed 2011·Granted Nov 11, 2014·8 cites·19 claims
- 0584US10183024B2Crystalline forms of ibrutinibAPOTEX INC·Filed 2017·Granted Jan 22, 2019·2 cites·5 claims
- 0680US11236066B2Crystalline forms of niraparib tosylateAPOTEX INC·Filed 2020·Granted Feb 1, 2022·1 cites·20 claims
- 0778US11046638B2Processes for the preparation of zuclomiphene and intermediates thereofAPOTEX INC·Filed 2020·Granted Jun 29, 2021·1 cites·17 claims
- 0878US7834195B2Atorvastatin calcium propylene glycol solvatesAPOTEX PHARMACHEM INC·Filed 2007·Granted Nov 16, 2010·2 cites·8 claims
- 0973US6436956B1Useful form of anhydrous paroxetine hydrochlorideBRANTFORD CHEM INC·Filed 1997·Granted Aug 20, 2002·17 cites·6 claims
- 1072US9382233B2Forms of vilazodone and processes for the preparation thereofAPOTEX INC·Filed 2013·Granted Jul 5, 2016·1 cites·10 claims
- 1171US10513500B2Crystalline forms of LesinuradAPOTEX INC·Filed 2017·Granted Dec 24, 2019·1 cites·15 claims
- 1270US11814356B1Salt of cabozantinibAPOTEX INC·Filed 2023·Granted Nov 14, 2023·0 cites·16 claims
- 1365US2024409547A1Solid Forms of UpadacitinibAPOTEX INC·Filed 2024·Application pending·0 cites
- 1464US2024116884A1Salts of ViloxazineAPOTEX INC·Filed 2023·Application pending·0 cites
- 1563US2024018090A1Processes for the Preparation of FenfluramineAPOTEX INC·Filed 2023·Application pending·0 cites
- 1662US11220500B2Crystalline form of Valbenazine dibesylateAPOTEX INC·Filed 2019·Granted Jan 11, 2022·0 cites·18 claims
- 1762US7087611B2Preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride (ziprasidone hydrochloride)APOTEX PHARMACHEM INC·Filed 2004·Granted Aug 8, 2006·2 cites·12 claims
- 1860US11578025B2Processes for the preparation of zuclomiphene intermediatesAPOTEX INC·Filed 2021·Granted Feb 14, 2023·0 cites·16 claims
- 1960US2025049774A1Crystalline Forms of ApalutamideAPOTEX INC·Filed 2022·Application pending·0 cites
- 2059US10662178B2Crystalline form of OlaparibAPOTEX INC·Filed 2019·Granted May 26, 2020·0 cites·14 claims
- 2159US10407396B2Crystalline form of selexipagAPOTEX INC·Filed 2018·Granted Sep 10, 2019·0 cites·19 claims
- 2259US7939662B2Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the sameAPOTEX PHARMACHEM INC·Filed 2007·Granted May 10, 2011·0 cites·34 claims
- 2359US7696183B2Ibandronate sodium propylene glycol solvate and processes for the preparation thereofAPOTEX PHARMACHEM INC·Filed 2006·Granted Apr 13, 2010·0 cites·7 claims
- 2459US2025019346A1Salts of Ruxolitinib and Crystalline Forms ThereofAPOTEX INC·Filed 2022·Application pending·0 cites
- 2558US7138523B2Preparation of 4-(4-fluorophenyl)-N-alkylnipecotinate esters, 4-(4-fluorophenyl)-N-arylnipecotinate esters and 4-(4-fluorophenyl)-N-aralkylnipecotinate estersAPOTEX PHARMACHEM INC·Filed 2002·Granted Nov 21, 2006·2 cites·21 claims
- 2656US7375233B2Process for the preparation of zonisamide and the intermediates thereofAPOTEX PHARMACHEM INC·Filed 2005·Granted May 20, 2008·0 cites·21 claims
- 2756US2008033181A1Process for the preparation of Zonisamide and the intermediates thereofAPOTEX PHARMACHEM INC·Filed 2007·Application pending·0 cites
- 2855US11661396B2Crystalline forms of zuclomiphene citrateAPOTEX INC·Filed 2021·Granted May 30, 2023·0 cites·23 claims
- 2955US11072620B2Crystalline forms of Ponatinib hydrochlorideAPOTEX INC·Filed 2018·Granted Jul 27, 2021·0 cites·16 claims
- 3055US2023093124A1Salts of Nintedanib and Crystalline Forms ThereofAPOTEX INC·Filed 2022·Application pending·0 cites
- 3154US5962689AStereoselective and useful preparation of 3-substituted 4-aryl piperidine compoundsBRANTFORD CHEM INC·Filed 1997·Granted Oct 5, 1999·6 cites·23 claims
- 3253US10632107B2Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2APOTEX INC·Filed 2019·Granted Apr 28, 2020·0 cites·16 claims
- 3351US2023279036A1Salts of RemdesivirAPOTEX INC·Filed 2021·Application pending·0 cites
- 3450US2021292272A1Salts of ZuclomipheneAPOTEX INC·Filed 2021·Application pending·0 cites
- 3549US2019390235A1Processes for the Preparation of Dasotraline and Intermediates ThereofAPOTEX INC·Filed 2019·Application pending·0 cites
- 3648US8188300B2Atorvastatin calcium propylene glycol solvatesMURTHY K S KESHAVA·Filed 2010·Granted May 29, 2012·0 cites·22 claims
- 3748US2008139845A1Ibandronate sodium propylene glycol solvate and processes for the preparation thereofAPOTEX PHARMACHEM INC·Filed 2007·Application pending·0 cites
- 3845US6132286APreparation of 1,2,5,6-tetra-hydro-3-carboalkoxypridines such as arecoline and salts of 1,2,5,6-tetrahydro-3-carboalkoxypridines and arecoline hydrobromideBRANTFORD CHEM INC·Filed 1997·Granted Oct 17, 2000·4 cites·19 claims
- 3944US8471011B2Preparation of acid addition salts of amine bases by solid phase—gas phase reactionsREY ALLAN W·Filed 2005·Granted Jun 25, 2013·0 cites·23 claims
- 4044US2005256139A1Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1, 3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the sameAPOTEX PHARMACHEM INC·Filed 2004·Application pending·0 cites
- 4141US7745624B2Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactionsAPOTEX PHARMA CHEM INC·Filed 2005·Granted Jun 29, 2010·0 cites·79 claims
- 4238US2017291882A1Solid Forms of MirabegronAPOTEX INC·Filed 2015·Application pending·0 cites
- 4333US2007265447A1Process for the Preparation of Ziprasidone (5-[2-[4-(1,2-Benziosothiazol-3-Y1)-1-Piperazinyl]Ethyl]-6-Chloro-1,3-Dihydro-2H-Indol-2- OneZETINA-ROCHA CARLOS·Filed 2005·Application pending·0 cites
- 4428US6008347AN-substituted 2-azetidinonesBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Dec 28, 1999·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Allan W. Rey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →